| Schedule of Reconciliation of Numerator and Denominator Used in Calculation of Basic and Diluted Net Income Per Share |
For the three months ended September 30, 2024 and 2023 and for the nine months ended September 30, 2024 and 2023, a reconciliation of the numerator and denominator used in the calculation of basic and diluted net income (loss) per share is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
|
Nine Months Ended
September 30, |
|
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated net income (loss) |
|
$ |
22,511 |
|
|
$ |
18,973 |
|
|
$ |
(24,909 |
) |
|
$ |
44,656 |
|
Net loss attributable to redeemable noncontrolling interest |
|
|
— |
|
|
|
(3,329 |
) |
|
|
— |
|
|
|
(10,191 |
) |
Net income (loss) attributable to common stockholders — basic |
|
$ |
22,511 |
|
|
$ |
22,302 |
|
|
$ |
(24,909 |
) |
|
$ |
54,847 |
|
Net loss attributable to redeemable noncontrolling interest |
|
|
— |
|
|
|
(3,329 |
) |
|
|
— |
|
|
|
(10,191 |
) |
Net income (loss) attributable to common stockholders — diluted |
|
$ |
22,511 |
|
|
$ |
18,973 |
|
|
$ |
(24,909 |
) |
|
$ |
44,656 |
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number of shares of common stock used
in computing net income (loss) per share attributable to
common stockholders — basic |
|
|
103,321,988 |
|
|
|
113,223,711 |
|
|
|
104,769,518 |
|
|
|
113,998,928 |
|
Dilutive effect of share equivalents resulting from stock
options |
|
|
108,869 |
|
|
|
224,061 |
|
|
|
— |
|
|
|
226,715 |
|
Dilutive effect of share equivalents resulting from
unvested restricted stock units |
|
|
1,628,426 |
|
|
|
874,507 |
|
|
|
— |
|
|
|
676,093 |
|
Weighted-average number of shares of common stock
used in computing net income per share attributable to
common stockholders — diluted |
|
|
105,059,283 |
|
|
|
114,322,279 |
|
|
|
104,769,518 |
|
|
|
114,901,736 |
|
Net income (loss) per share attributable to common stockholders: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.22 |
|
|
$ |
0.20 |
|
|
$ |
(0.24 |
) |
|
$ |
0.48 |
|
Diluted |
|
$ |
0.21 |
|
|
$ |
0.17 |
|
|
$ |
(0.24 |
) |
|
$ |
0.39 |
|
|
| Schedule of Potentially Dilutive Common Stock Equivalents Excluded from Calculation of Diluted Weighted-average Shares Outstanding |
For the three months ended September 30, 2024 and 2023 and for the nine months ended September 30, 2024 and 2023, potentially dilutive common stock equivalents that have been excluded from the calculation of diluted weighted-average shares outstanding as their effect would have been anti-dilutive are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
|
Nine Months Ended
September 30, |
|
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
Stock options outstanding |
|
|
506,554 |
|
|
|
548,695 |
|
|
|
701,884 |
|
|
|
555,601 |
|
Restricted stock units outstanding |
|
|
512,198 |
|
|
|
2,035,557 |
|
|
|
6,264,428 |
|
|
|
2,511,429 |
|
|